Closer Pharma-Diagnostic Collaboration is Key to Alzheimer’s Drug R&DByEdward I. Ginns, MD, PhDNovember 1st 2018Pharma and diagnostics companies need to strengthen alignment in Alzheimer’s disease research-to help turn science and data into actionable medical innovations.